CR Ventures
VC Fund
Singapore, Singapore
CR Ventures is a global life-science investor with a focus on pharmaceutical, diagnostic, and other medical technology clinical trials. CR Ventures has offices in Boston and Europe and invests globally.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries CR Ventures invests in
Stages CR Ventures invests in
Countries CR Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Fred Sauniere
|
|||
Nuno Arantes-Oliveira
|
|||
Peter Kovacs
|
|||
Investment Focus
Industry
- Biotechnology 3 (100%)
- Pharmaceutical 2 (67%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Clinical Trials 1 (33%)
Stage
- Series A 2 (67%)
- Seed 1 (33%)
Country
- United States 2 (67%)
- Switzerland 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Fred Sauniere
Partner
|
Partner | Total investments: 0 | Find email | |
|
Nuno Arantes-Oliveira
Founder & Partner
|
Founder & Partner | Total investments: 0 | Find email | |
|
Peter Kovacs
Managing Partner
|
Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Adiposs
|
Adiposs is a Swiss biotech start-up company developing medical imaging products and technologies for early detection of cachexia. | $2M / Seed / Dec 24, 2021 | |
Xeno Biosciences
|
Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts. | $7.3M / Series A / Aug 08, 2021 | |
Astrocyte Pharmaceuticals
|
Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease. | $6M / Series A / May 03, 2021 |
Co-Investors
Boston Harbor Angels
2 deals together
Sidecar Angels
2 deals together
Beacon Angels
1 deal together
DREAMERS Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does CR Ventures invest in?
CR Ventures invests primarily in Biotechnology, Pharmaceutical and Health Care startups, most often at Series A and Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CR Ventures?
Public channels for CR Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CR Ventures?
The team at CR Ventures includes Fred Sauniere (Partner), Nuno Arantes-Oliveira (Founder & Partner) and Peter Kovacs (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
